1.Episodes of prolonged “trance-like state” in an infant with hypothalamic hamartoma
Rakesh KUMAR ; Jaivinder YADAV ; Jitendra Kumar SAHU ; Manjul TRIPATHI ; Chirag AHUJA ; Devi DAYAL
Annals of Pediatric Endocrinology & Metabolism 2019;24(1):55-59
Hypothalamic hamartoma (HH) is one of the most common causes of central precocious puberty (CPP) in first few years of life. It can present with either seizures or CPP, although both manifestations coexist in the majority of the children. Gelastic seizures (GS), or laughing spells, are usually the first type of seizures seen in patients with HH. Although a wide variety of seizure types are known to occur in children with HH, GS are most common and consistent seizure type. The clinical presentation of HH may vary with the size and position of the mass, although large tumours typically present with both CPP and seizures. Although CPP can be managed with medical therapy, seizures can be very difficult to treat, even with multiple antiepileptic drugs. Noninvasive gamma knife surgery has been used with some success for the treatment of refractory epilepsy. We present a case of HH with very early onset seizures and CPP. The patient had an atypical form of seizures described by the parents as a "trance-like state" in which the patient had prolonged episodes of unresponsiveness lasting for hours with normal feedings during the episodes. GS occurred late in the course and were refractory to various combinations of antiepileptic drugs. A brain magnetic resonance imaging showed a large sessile HH (>20 mm). Later in the course of the disease, the patient experienced cognitive and behavioural problems. The patient underwent gamma knife surgery at nearly 5 years of age and experienced a modest response in seizure frequency. This case highlights the presentation of HH as a previously unreported seizure morphology described as a prolonged "trance-like state."
Anticonvulsants
;
Brain
;
Child
;
Epilepsy
;
Hamartoma
;
Humans
;
Infant
;
Magnetic Resonance Imaging
;
Parents
;
Puberty, Precocious
;
Seizures
;
Tuber Cinereum
2.The Diagnostic Dilemma of Neurolymphomatosis.
Ritu SHREE ; Manoj Kumar GOYAL ; Manish MODI ; Balan Louis GASPAR ; Bishan Dass RADOTRA ; Chirag Kamal AHUJA ; Bhagwant Rai MITTAL ; Gaurav PRAKASH
Journal of Clinical Neurology 2016;12(3):274-281
Neurolymphomatosis (NL) defined as infiltration of the central nervous system or the peripheral nervous system (PNS) by malignant lymphoma cells is a rare clinical entity. However, the increasing use of fluorodeoxyglucose positron-emission tomography (FDG-PET) and magnetic resonance imaging in evaluating PNS disorders is resulting in; this condition being recognized more frequently. Here; we report five NL patients and review the current literature. We report five patients with non-Hodgkin's lymphoma (NHL) and NL, all of whom were men aged 47-69 years. The clinical presentation varied from symmetrical peripheral neuropathy to mononeuropathy. Peripheral neuropathy was the presenting manifestation of a systemic lymphoma in two patients (40%). Neuroimaging as well as whole-body FDG-PET helped in determining the correct diagnosis in all of the patients. NL is an unusual presentation of NHL resulting from infiltration of the PNS by malignant lymphomatous cells. While evaluating peripheral neuropathy, a high degree of suspicion of NL is required since the presenting symptoms vary, conventional radiology has only modest sensitivity, and a pathological diagnosis is often difficult. FDG-PET helps in the early diagnosis and treatment of this condition.
Animals
;
Central Nervous System
;
Diagnosis
;
Early Diagnosis
;
Humans
;
Lymphoma
;
Lymphoma, Non-Hodgkin
;
Magnetic Resonance Imaging
;
Male
;
Marek Disease*
;
Mononeuropathies
;
Neuroimaging
;
Peripheral Nervous System
;
Peripheral Nervous System Diseases
;
Positron-Emission Tomography
3.The Diagnostic Dilemma of Neurolymphomatosis.
Ritu SHREE ; Manoj Kumar GOYAL ; Manish MODI ; Balan Louis GASPAR ; Bishan Dass RADOTRA ; Chirag Kamal AHUJA ; Bhagwant Rai MITTAL ; Gaurav PRAKASH
Journal of Clinical Neurology 2016;12(3):274-281
Neurolymphomatosis (NL) defined as infiltration of the central nervous system or the peripheral nervous system (PNS) by malignant lymphoma cells is a rare clinical entity. However, the increasing use of fluorodeoxyglucose positron-emission tomography (FDG-PET) and magnetic resonance imaging in evaluating PNS disorders is resulting in; this condition being recognized more frequently. Here; we report five NL patients and review the current literature. We report five patients with non-Hodgkin's lymphoma (NHL) and NL, all of whom were men aged 47-69 years. The clinical presentation varied from symmetrical peripheral neuropathy to mononeuropathy. Peripheral neuropathy was the presenting manifestation of a systemic lymphoma in two patients (40%). Neuroimaging as well as whole-body FDG-PET helped in determining the correct diagnosis in all of the patients. NL is an unusual presentation of NHL resulting from infiltration of the PNS by malignant lymphomatous cells. While evaluating peripheral neuropathy, a high degree of suspicion of NL is required since the presenting symptoms vary, conventional radiology has only modest sensitivity, and a pathological diagnosis is often difficult. FDG-PET helps in the early diagnosis and treatment of this condition.
Animals
;
Central Nervous System
;
Diagnosis
;
Early Diagnosis
;
Humans
;
Lymphoma
;
Lymphoma, Non-Hodgkin
;
Magnetic Resonance Imaging
;
Male
;
Marek Disease*
;
Mononeuropathies
;
Neuroimaging
;
Peripheral Nervous System
;
Peripheral Nervous System Diseases
;
Positron-Emission Tomography
4.Clinical behaviour and outcome in pediatric glioblastoma: current scenario
Aditya Kumar SINGLA ; Renu MADAN ; Kirti GUPTA ; Shikha GOYAL ; Narendra KUMAR ; Sushant Kumar SAHOO ; Deepak K. UPPAL ; Chirag K. AHUJA
Radiation Oncology Journal 2021;39(1):72-77
Pediatric glioblastoma (pGBM) is a rare entity accounting for only approximately 3% of all childhood brain tumors. Treatment guidelines for pGBM have been extrapolated from those in adult glioblastoma. Rarity of pGBM and underrepresentation of pediatric population in major studies precludes from defining the ideal treatment protocol for these patients. Maximum safe resection is performed in most of the cases followed by postoperative radiotherapy in children over 3 years of age. Benefit of temozolomide is unclear in these patients. Here, we present the clinicopathological details and outcome of six pGBM patients treated at our institute in 2018–2019.
5.Clinical behaviour and outcome in pediatric glioblastoma: current scenario
Aditya Kumar SINGLA ; Renu MADAN ; Kirti GUPTA ; Shikha GOYAL ; Narendra KUMAR ; Sushant Kumar SAHOO ; Deepak K. UPPAL ; Chirag K. AHUJA
Radiation Oncology Journal 2021;39(1):72-77
Pediatric glioblastoma (pGBM) is a rare entity accounting for only approximately 3% of all childhood brain tumors. Treatment guidelines for pGBM have been extrapolated from those in adult glioblastoma. Rarity of pGBM and underrepresentation of pediatric population in major studies precludes from defining the ideal treatment protocol for these patients. Maximum safe resection is performed in most of the cases followed by postoperative radiotherapy in children over 3 years of age. Benefit of temozolomide is unclear in these patients. Here, we present the clinicopathological details and outcome of six pGBM patients treated at our institute in 2018–2019.